Age Related Macular Degeneration
178
10
13
108
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
20 trials with published results (11%)
Research Maturity
108 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.1%
9 terminated out of 178 trials
92.3%
+5.8% vs benchmark
20%
35 trials in Phase 3/4
19%
20 of 108 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 108 completed trials
Clinical Trials (178)
Village-Integrated Eye Worker Trial II - Pilot
Strategies for Improving Linkage-to-Care After Eye Disease Screening
Assay of Pro-angiogenic Cytokines in Exudative Age-Related Macular Degeneration
AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
A Snapshot Adaptive Optics and Hyperspectral Autofluorescence Fundus Camera for Age-Related Macular Degeneration (AMD)
Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort
High Resolution Imaging OCT Study
Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration
Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting
Phase 2/3 Study of ALK-001 in Geographic Atrophy
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression
Smartphone Screening for Eye Diseases
Effect of Video Viewing on Intravitreal Injection Experience
Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degeneration
Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients